Novo Nordisk AS
Pharmaceuticals
Denmark
2011 IW 1000 Rank:
Current Rank : 354
Prior Rank : 364
Executive 1 : Lars Rebien Sorensen, President; Chief Executive Officer
Executive 2 : Jesper Brandgaard, Executive Vice President; Chief Financial Officer
| Total Company Assets | $11,022 |
| Revenue (US$ Millions) | $11,027 |
| Revenue Growth (%) | 19.48% |
| Net Income (US$ Millions) | $2,585 |
| Earnings Per Share (US$) | $4.42 |
| Total Equity (US$ Millions) | $6,635 |
| Profit Margin (%) | 23.45% |
| Return on Assets (%) | 26.31% |
| Debt To Equity Ratio (%) | 0.01% |
IndustryWeek Articles about Novo Nordisk AS: